A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma

http://www.wikidata.org/entity/Q35085830

about

EGFR Signaling in Liver Diseases Molecular prognostic prediction in liver cirrhosis Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Hepatitis C virus and hepatocarcinogenesis Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.Processes to manage analyses and publications in a phase III multicenter randomized clinical trial Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.Host genetics predict clinical deterioration in HCV-related cirrhosis.Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection Hepatocellular carcinoma: clinical frontiers and perspectives.Kenneth tanabe works to solve the mysteries of liver cancer: while progress has been relatively slow, this noted expert sees reasons for hope.Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.Hepatitis C virus-induced hepatocellular carcinoma Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Host genetic variants influencing the clinical course of hepatitis C virus infection.Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.

P2860

Q26771265-858E9A0F-EC7D-4DB2-AFF8-8BFCEF085C5E Q26784251-A36C276B-9B2D-4C66-9085-B007779744C3 Q27002288-DFCD063E-E1A4-4491-8DE8-A7D2B9166F3D Q28066959-77E481AD-BB80-4EE1-8909-9633716CDA5D Q28272678-AD2AAE6C-8853-426B-BD9A-773036F6AE04 Q28283484-1F8342D9-8881-4C27-BA31-7C62910B594F Q28468624-9E4011DB-EBEF-4C51-B373-45170C64EE44 Q33572715-AEA7C726-9BDE-4921-B770-A09ED432853D Q33694159-40D56F7B-4AFF-41E4-ABF0-49B8E7EEE7CA Q33723810-CC096EBE-1A67-4514-8F4E-963DF45DCD7F Q33795154-BD57A7A7-13F9-4CBC-B7C2-1AC398B3B5FB Q33899640-80F8A4FE-8CC5-460C-9E5E-8F6138B38427 Q33920344-9097EA53-5A9F-4C11-88EE-E4B9E5B54572 Q34123927-6D3292C0-73F1-4870-B867-3039E2BC6981 Q34189361-8F3CB30F-8580-449B-BB7D-75D23655DD76 Q34361442-D24FFE02-2175-4C2E-A086-BC997E41BC37 Q34590768-379014A6-8FE7-4810-8740-2FE87563BF2B Q34689664-F35BC906-0620-4951-8F61-FB6E1788A440 Q34991214-B3C76D42-26DC-4CF3-B6CE-0E5E5F3FC31B Q35051824-A20BE664-C3BD-4822-BCE8-61345EF3B5CB Q35112053-7611AC5B-33D2-4FE2-969D-B1B4DD5E31CC Q35229774-31C3D957-6E3B-46F3-8B30-562717C40BC2 Q35564471-CA8A12D5-E898-4A57-9455-C2DB7CA812A4 Q35619104-B2FF907E-4E92-4695-B3D9-A76F6B1F23A9 Q35632101-D8F61BB6-FE1F-4493-9175-9AA351352904 Q35824057-143F77AA-C0FB-41CA-AED1-4C8D4D9CE342 Q35881575-008ACF93-7FEC-4286-8998-F6A491EB06DD Q36199751-51F30FF8-0B86-4EAD-B83D-7AEDB1053B58 Q36335379-E6C12BFD-BB33-45D2-92EE-667190AE4965 Q36625697-02062A50-7C71-4F05-A06F-E1A1E120D5FD Q36699256-C88FE123-0DF0-4E65-8F5D-93252DF101D8 Q36710902-B39858D9-953C-4886-969C-DB58680228A4 Q36788468-A339611B-4D59-4CFD-8881-5D7AF3C97EA0 Q36904033-DE869754-8948-4572-B2BE-3352E8E22DC7 Q37067080-F36A8806-F5C1-4435-A597-D56BFB79B449 Q37398922-712C4D1E-8A58-4EB0-B5D5-B9DB2074C853 Q37584311-7E22B8D7-8F46-4431-9C15-26BF74D60D10 Q38046452-4FFD7B0C-D80F-478A-842F-C7E6314DCF6D Q38554500-59804D87-E6FC-4CF3-9522-DE8D5ED9AA61 Q38584060-6CBB04B9-7A5B-47FA-85DE-240646D1EE87

P2860

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma

http://www.wikidata.org/entity/Q35085830

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A functional polymorphism in t ...... k for hepatocellular carcinoma

@ast

A functional polymorphism in t ...... k for hepatocellular carcinoma

@en

type

label

A functional polymorphism in t ...... k for hepatocellular carcinoma

@ast

A functional polymorphism in t ...... k for hepatocellular carcinoma

@en

prefLabel

A functional polymorphism in t ...... k for hepatocellular carcinoma

@ast

A functional polymorphism in t ...... k for hepatocellular carcinoma

@en

P1433

Q35085830-2E29A50C-D901-4268-9BEB-D1016E268DAC

P1476

Q35085830-1042A2FA-8DF8-47C9-9C79-996CA64D2A1C

P2093

Q35085830-158210CE-8FD7-4A1E-82E4-B0EECAA3EA8F

Q35085830-2E0D2CFA-43A9-4CCD-AB64-58080DC1070F

Q35085830-46489A97-DFB5-4D6A-A110-72549D20B3B6

Q35085830-4B9E4CD6-7A74-487E-95F1-1F200A32255A

Q35085830-4C169198-AA4F-4832-A672-16CD439E8985

Q35085830-6D506C23-0205-4200-BCC6-36A524155412

Q35085830-86EF2A74-E192-4497-A581-51D70253437E

Q35085830-8B34017B-639E-40E0-AD82-A1F11FF51243

Q35085830-F1D52F29-913D-4A19-942B-0E0DF228BBB5

Q35085830-F947A8EA-4B4D-437A-BDC1-1129F9703EE4

P2860

Q35085830-03CB6D38-F9B7-447B-A563-1AD6EA0C9EF3

Q35085830-07071481-8553-4F59-AA76-318174ACC624

Q35085830-2134417C-FC8F-40F0-BB8A-BDD0EE9E4F91

Q35085830-2E8998FA-C9BB-4687-9564-1B007A3806BA

Q35085830-352F1101-E083-4DA3-BF1C-3FDA27C30A62

Q35085830-41D6E803-4A40-49D2-AE5F-FE98E995E654

Q35085830-469E541B-3C98-42E0-B59C-F652B097F8CE

Q35085830-5C290A8C-E941-46EE-9CDB-A5D412C1605D

Q35085830-5F0F9194-12BE-40E7-BA3A-8E41E4DB6E47

Q35085830-64AAD599-E337-4700-9478-AEB1D434DEB4

P304

Q35085830-4F3EA2D1-630E-403A-A175-53CD29742292

P31

Q35085830-9476C0D1-753B-4716-85AE-EF81545CE824

P356

Q35085830-5E661251-7267-4FB3-B1CD-AC36A9BD7FBA

P407

Q35085830-759967BC-0E45-4E80-BFE8-D2BAAB129C22

P433

Q35085830-702B6316-4BD0-4358-B79C-BFAAFBBD35EA

P478

Q35085830-BF077B2D-648B-402A-B66E-6AE989F82E3A

P50

Q35085830-2478FE23-879E-4F06-923C-D472E315FDCE

P577

Q35085830-F3035383-876A-41CA-84DC-2332601570C0

P698

Q35085830-537AACC0-1C2C-4C64-9EEB-B380F28EE912

P932

Q35085830-5E26D95C-0D87-478A-B570-28A8F804DDBA

P356

J.GASTRO.2011.03.045

P1433

Gastroenterology

P1476

A functional polymorphism in t ...... k for hepatocellular carcinoma

@en

P2093

Barham K Abu Dayyeh

http://www.w3.org/2001/XMLSchema#string

Bryan C Fuchs

http://www.w3.org/2001/XMLSchema#string

Daniel L Karl

http://www.w3.org/2001/XMLSchema#string

HALT-C Trial Group

http://www.w3.org/2001/XMLSchema#string

John J Sninsky

http://www.w3.org/2001/XMLSchema#string

Jules L Dienstag

http://www.w3.org/2001/XMLSchema#string

Kenneth K Tanabe

http://www.w3.org/2001/XMLSchema#string

May Yang

http://www.w3.org/2001/XMLSchema#string

Suguru Yamada

http://www.w3.org/2001/XMLSchema#string

Thomas R O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Global cancer statistics, 2002

The global health burden of infection-associated cancers in the year 2002

Management of hepatocellular carcinoma

Histological grading and staging of chronic hepatitis

Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

P304

141-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2011.03.045

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

Raymond T Chung

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21440548

http://www.w3.org/2001/XMLSchema#string

P932

3129453

http://www.w3.org/2001/XMLSchema#string